Compared to Estimates, Clorox (CLX) Q4 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Clorox (CLX) reported revenue of $1.99 billion, up 4.5% over the same period last year. EPS came in at $2.87, compared to $1.82 in the year-ago quarter.The reported revenue represents a surprise of +3.04% over the Zacks Consensus Estimate of $1.93 billion. With the consensus EPS estimate being $2.24, the EPS surprise was +28.12%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Clorox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Organic Revenue Growth - Health and Wellness: 14% compared to the 6.3% average estimate based on four analysts.Organic Revenue Growth - International: 1% versus the four-analyst average estimate of 2.4%.Organic Revenue Growth - Lifestyle: 3% compared to the 6.3% average estimate based on four analysts.Organic Revenue Growth - Household: 7% versus the four-analyst average estimate of 4.6%.Organic Sales Growth: 8% compared to the 5.4% average estimate based on four analysts.Net Revenue- Health and Wellness: $741 million compared to the $692.86 million average estimate based on four analysts. The reported number represents a change of +13.7% year over year.Net Revenue- International: $269 million compared to the $249.98 million average estimate based on four analysts. The reported number represents a change of -0.7% year over year.Net Revenue- Lifestyle: $339 million compared to the $349.59 million average estimate based on four analysts. The reported number represents a change of +3.4% year over year.Net Revenue- Household: $639 million compared to the $626.55 million average estimate based on four analysts. The reported number represents a change of +7% year over year.Income before income taxes- Health and Wellness: $243 million compared to the $219.1 million average estimate based on two analysts.Income before income taxes- Corporate and Other: $-56 million compared to the $-26.67 million average estimate based on two analysts.Income before income taxes- International: $23 million compared to the $21.21 million average estimate based on two analysts.View all Key Company Metrics for Clorox here>>>Shares of Clorox have returned +1.2% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Clorox Company (CLX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks